ArticleWiener klinische Wochenschrift2017
Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
Florian Huemer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it